Delivery Order SPE2DB20D3103-SPE2DB23FL5K0
Award Date 11/4/22
Potential Completion Date 11/7/22
Potential Value $3.4K
Federal Agency
Awardee
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $8,027.93, is for the delivery of XYLOCAINE-MPF 2% 40 MG/2 ML VL 2ML, a pharmaceutical product. The contract is a delivery order with a firm fixed price and has an ultimate completion date of July 3, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
- This federal contract award is for the delivery of Lidocaine HCL 1% ampules to the Defense Logistics Agency (DLA). The $1,224.48 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of December 16, 2022. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which does business as Amerisourcebergen. The company holds a significant...
- This federal contract award is for the delivery of Lidocaine HCL 1% in 10 ml vials, valued at $1,991.04, from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract has an ultimate completion date of April 30, 2024 and was awarded on April 29, 2024 with a firm fixed price. Amerisourcebergen Drug Corp, a major pharmaceutical distributor, holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to...
- This federal contract award is for the delivery of Lidocaine HCL 2% 200 mg/10 ml 10 ml to the Defense Logistics Agency (DLA) Troop Support Medical. The award, valued at $1,914.74, was made to Amerisourcebergen Drug Corp, a for-profit subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. This is a firm fixed price delivery order contract with a completion date of March 25, 2024. Amerisourcebergen Drug Corp serves as a prime...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,790.11 firm fixed-price delivery order is for the supply of XYLOCAINE-MPF 2% 40 MG/2 ML VL 2ML, a pharmaceutical product, with a period of performance ending on October 31, 2024. The award is not designated as a set-aside contract. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract...
- This federal contract award is for the delivery of Lidocaine HCL 2% Vial 2ML, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract was awarded to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, on August 16, 2024. The contract has a ceiling value of $4,102.24 and an ultimate completion date of August 19, 2024. The contract is a Delivery Order with a Firm Fixed Price pricing type. This award is not...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order under an Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical, valued at up to $999,999,999.00 through December 2025. The delivery order is for the supply of 4559738273 - Lidocaine HCL 1% Vial 2ML, a pharmaceutical product, at a ceiling value of $1,524.90. The contract is a firm-fixed-price arrangement with no set-aside designation, indicating...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation's Corporate Office Division. The contract, valued at $1,179.40, is for the delivery of pharmaceutical products, specifically XYLOCAINE-MPF 1%-EPI 1:200,000 30ML, to support various government agencies and healthcare programs. The contract is a firm fixed-price Delivery Order, with a period of performance running through September 2024. Amerisourcebergen, a major supplier of...
- This federal contract award is for the delivery of Lidocaine 1%-Epi 1:100,000 50ml, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract, valued at $1,460.94, was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., on March 8, 2022, with a completion date of March 9, 2022. The contract is a Firm Fixed Price Delivery Order, without any set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, the prime contractor. The contract is for the delivery of XYLOCAINE 2% VIAL 20ML, a pharmaceutical product, with a ceiling value of $1,637.26 and a period of performance through March 14, 2024. Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, is a for-profit organization that serves as a prime contractor providing a wide range of pharmaceutical products and...